Your browser doesn't support javascript.
loading
Nintedanib alleviates pulmonary fibrosis in vitro and in vivo by inhibiting the FAK/ERK/S100A4 signalling pathway.
Yang, Wenting; Pan, Lin; Cheng, Yiju; Wu, Xiao; Tang, Bin; Zhu, Honglan; Zhang, Menglin; Zhang, Yuquan.
Afiliação
  • Yang W; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Pan L; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Cheng Y; Department of Respiratory and Critical Care Medicine, The First People's Hospital of Guiyang, Guiyang 550004, China; Guizhou Medical University, Guiyang 550004, China. Electronic address: chengchengyiju@126.com.
  • Wu X; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Tang B; Department of Pathology, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Zhu H; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Zhang M; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Zhang Y; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
Int Immunopharmacol ; 113(Pt A): 109409, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36461602
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article